Article
Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer.
Journal of clinical gastroenterology - 1 Jan 2015
Bournet Barbara, Selves Janick, Grand David, Danjoux Marie, Hanoun Naima, Cordelier Pierre, Buscail Louis
Abstract excerpt
GOALS AND BACKGROUND: Mutation of the KRAS oncogene is present in 75% to 95% of pancreatic cancer tissues. This study aimed to evaluate whether endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), combined with analysis of the KRAS mutation, improves the diagnosis of pancreatic cancer in cases of inconclusive or doubtful cytopathologic analysis. PATIENTS AND METHODS: We prospectively included 186...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
